Neurovascular Unit for Aged Patients With Geriatric Care and Evaluation of Factors Associated With Autonomy Loss

There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise acquired over many years. However, to date, the profiles of patients included in these units and the factors associated with loss of independence and the outcomes of older patients hospitalized in neurovascular units for older adults remain unknown. In this context, the NUAGE study aims to describe the population cared for in this unit and analyze the factors associated with patient outcomes.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital des Charpennes (Hospices Civils de Lyon)

Villeurbanne, 69100, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

- Patients over 65 years of age
Hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne

Exclusion criteria

- Patients, relatives/trusted individuals, legal representatives who object to the research

Treatment and study plan

Not applicable- observational study

Other

not applicable - observational study

Primary outcomes

Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS).

Time frame: Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.

The following data will be collected to describe the characteristics of the study population :

Age (years) Gender (F/M) IMC (kg/m²) Smoking/alcohol consumption Comorbidities (Charlson score) Presence/Absence of Hypertension, DiabetesTreatment Type of stroke (ischemic or hemorrhagic) + Artery involved Complications related to treatment (falls, spastic pain, swallowing disorders, malnutrition, infections, bedsores, epilepsy) Biological parameters (cholesterol (g/L), albumin (g/L)) Cognitive and cardiovascular assessments related to stroke assessment (cardiac ultrasound, arterial Doppler ultrasound, radiocinema) National Institutes of Health Stroke Scale (NIHSS) Modified Rankin Scale (mRS) Measure of functional independence (MIF) Type of discharge (death, institutionalization, return home)

Study contacts

Contact information is provided by the study sponsor or research team.

Marie M BRETON, MD

CONTACT

[email protected]

04.72.43.21.18 ext. 0033

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: NUAGE

Important dates

Study start: 2026
Primary completion: 2030
Study completion: 2031
First posted: Sep 4, 2026
Registry last updated: Sep 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not yet recruiting